Metastatic Breast Cancer
Clinical Trial - Toledo
Have you taken Ibrance® or Kisqali®? The Amelia 1 clinical trial is OPEN in Toledo. Please email the Toledo study manager or call 419 214-4236 (Ask about study SDX-0103.
Toledo Clinic Clinical Research
**Open to Recruitment
3450 W. Central Ave., Suite 230
Toledo, OH 43606
Contact: Pam Shoup, CCRP Director
(419) 214-4236
Principal Investigator: Dr. Rex Mowat
Has Your Breast Cancer Spread Despite CDK 4/6 Treatment?
The Amelia 1 breast cancer clinical trial is testing patients with the PIK3CA gene mutation. Post-menopausal women with advanced or metastatic breast cancer who live in the Toledo area are invited to apply to join the trial. Please contact the Toledo Clinic Clinical Research today, using the above information, for more details.
Amelia 1 is a clinical study developed by SynDevRx, Inc.
SynDevRX, Inc. Copyright 2022
Terms of Use
|
Privacy Policy
View our Clinical Trial Site Pages below for more details
